Acute effects of oral glibenclamide on blood pressure and forearm vascular resistance in diabetics

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 5, 1997, Pages 333-335

  Sundaresan, Purnima ^a   Lykos, Denise ^a   Daher, Ali ^a   Morris, Richard ^b   Diamond, Terence ^b   Howes, Laurence G ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

ATP sensitive potassium channels; blood pressure; diazoxide; non insulin dependent diabetes; sulfonylureas

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLIBENCLAMIDE; SULFONYLUREA;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FOREARM BLOOD FLOW; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PLETHYSMOGRAPHY; RANDOMIZED CONTROLLED TRIAL; VASCULAR RESISTANCE; VASODILATATION;

EID: 0030919170     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb01197.x     Document Type: Article

References (13)

1. Lebowitz H, Oral antidiabetic agents. In: Kahn CR, Weir GC (eds). Joslin's Diabetes Mellitus. Lea & Febiger, Pennsylvania. 1994; 508-29.
2. + channels. Annu. Rev. Pharmacol. Toxicol. 1993; 33: 597-637.
3. McPherson G. Current trends in the study of potassium channel openers. Gen. Pharmacol. 1993; 24: 275-81.
4. 86Rb flux studies in rabbit isolated vascular smooth muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 1991; 343: 70-5.
5. + channel activators, RP 52891, cromakalim and diazoxide, on the plasma renin activity and blood pressure in rats. J. Pharmacol. Exp. Ther. 1991; 258: 216-22.
6. Steinberg MI, Wiest SA, Zimmerman KM, Ertel PJ, Bemis KG, Robertson DW. Chiral recognition of pinacidil and its 3-pyridyl isomer by canine cardiac and smooth muscle: Antagonism by sulfonylureas. J. Pharmacol. Exp. Ther. 1991; 256: 222-9.
7. Tosaki A, Szerdahelyi P, Engelman RM, Das DK. Potassium channel openers and blockers: Do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts. J. Pharmacol. Exp. Ther. 1993; 267: 1355-62.
8. Bijlstra PJ, Smits P, Lutterman JA, Thein T. Glibenclamide inhibits the vasodilator effect of diazoxide in man. J. Hypertens. 1994; 12(Suppl. 3): S104.
9. Chan JCN, Tomlinson B, Critchley JA, Cockram CS, Walden RJ. Metabolic and haemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients. Diabetes Care 1993; 16: 1035-8.
10. Egan B, Stepniakowski K. Compensatory hyperinsulinemia and the forearm vasodilator response during an oral glucose-tolerance test in obese hypertensives. J. Hypertens. 1994; 12: 1061-7.
11. Schmidtt J, Moore J. Hypertension secondary to chlorpropamide with amelioration by changing to insulin. Am. J. Hypertens. 1993; 6: 317-19.
12. Cooper GJS. A reappraisal of current hypotheses concerning the possible roles of amylin in physiology, pathology and therapeutics. Clin. Sci. 1995; 88: 7-12.
13. Taddei S, Virdis A, Matttei P, Natali A, Ferrannini E, Salvetti A. Effect of insulin on acetylcholine induced vasodilation in normotensive subjects with essential hypertension. Circulation 1995; 92: 2911-18.